SINOMED(SH:688108) Sou Hu Cai Jing·2025-05-06 12:50Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Sino Medical, noting its high PE ratio compared to industry averages [1][2] - As of May 6, Sino Medical's stock closed at 9.89 yuan, with a PE ratio of 665.98, marking a new low in 20 days, and a total market capitalization of 4.089 billion yuan [1] - The average PE ratio for the medical device industry is 48.90, with a median of 36.41, positioning Sino Medical at the 120th rank within the industry [1][2] Group 2 - As of March 31, 2025, Sino Medical had 11,044 shareholders, an increase of 381 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company's main business focuses on the research, production, and sales of high-end interventional medical devices, primarily coronary stent systems and balloon dilation catheters [1] - The latest quarterly report for Q1 2025 shows Sino Medical achieved a revenue of 101 million yuan, a year-on-year increase of 10.75%, and a net profit of 2.9693 million yuan, reflecting a significant year-on-year growth of 277.50% with a gross margin of 59.66% [1]